Wiki · Peptide

CJC + Ipa

CP10 · 10mg · 10mg · 1 vial per kit

GHRH analog + selective ghrelin agonist.

Read the long-form research →

Storefront

/products/cjc-1295-ipamorelin

Markdown alternate

/products-md/cjc-1295-ipamorelin

Research-data API

/api/research-data/cjc-1295-ipamorelin

Pricing

$75 · sub $67.50 · stack-floor $60

Mechanism

CJC-1295 is a synthetic GHRH analog that binds the GHRH receptor on pituitary somatotrophs; Ipamorelin is a selective GHSR (ghrelin receptor) agonist. Together in vitro they activate complementary growth-hormone-secretion pathways without significant ACTH/cortisol/prolactin cross-activation.

In-vitro applications

GHRH-receptor activation
cAMP accumulation in HEK293 cells expressing recombinant GHRH-R.
Working range: nM range
GHSR selectivity profiling
Comparative receptor-binding panels vs other ghrelin-receptor agonists.
Working range: nM range

Researchers commonly co-treat with

MK-677 (Ibutamoren) — Orally-active GHSR agonist comparator.
Sermorelin — Shorter-half-life GHRH analog comparator.

Storage and handling

· Lyophilized: −20°C or below, desiccated
· Reconstituted: 2–8°C, use within 30 days
· Light + air: Protect from light and air
· Solubility: Soluble in bacteriostatic water (0.9% benzyl alcohol)

See also: lyophilization · reconstitution

Selected peer-reviewed citations

Teichman SL, et al. (2006). Prolonged stimulation of GH and IGF-I secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism.
Raun K, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology.

Bundled in stacks

· The Growth Stack — $329.97
· The Flagship — Aurex Elite — $1,299.97

Aurex does not provide dosage or use guidance — Federal regulations governing research-chemical distribution prohibit it. CJC + Ipa is distributed strictly for in-vitro laboratory research. Not for human or veterinary use. Not FDA approved. See research-use-only.